<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04972058</url>
  </required_header>
  <id_info>
    <org_study_id>PNA1DB-Stroke</org_study_id>
    <nct_id>NCT04972058</nct_id>
  </id_info>
  <brief_title>Philippine Neurological Association One Database - Stroke</brief_title>
  <acronym>PNA1DB-Stroke</acronym>
  <official_title>Philippine Neurological Association One Database - Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philippine Neurological Association</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philippine Neurological Association</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pragmatic, multi-center, prospective, observational, non-interventional study and&#xD;
      standing database of patients hospitalized for transient ischemic attack (TIA) or stroke in&#xD;
      the 11 accredited adult neurology training institutions in the Philippines. Data will be&#xD;
      collected from each patient while admitted in the hospital and until hospital discharge. Data&#xD;
      collection for this study will span 3 years from study initiation, after which the utility of&#xD;
      an extension or a re-implementation of the study will be assessed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary objective is to prospectively collect data on demographics, medical history,&#xD;
      in-hospital management, and outcomes among patients with first or recurrent TIA or ischemic&#xD;
      or hemorrhagic stroke admitted in accredited adult neurology training institutions in the&#xD;
      Philippines.&#xD;
&#xD;
      Secondary objectives are:&#xD;
&#xD;
        1. To determine the in-patient case load of first and recurrent TIA and stroke.&#xD;
&#xD;
        2. To determine the profile of patients admitted for first or recurrent TIA or stroke.&#xD;
&#xD;
        3. To determine the types of diagnostic and therapeutic management received by patients&#xD;
           with first or recurrent TIA or stroke.&#xD;
&#xD;
        4. To determine the outcomes of patients with first or recurrent TIA or stroke at the time&#xD;
           of hospital discharge.&#xD;
&#xD;
        5. To evaluate factors that predict outcome among patients with first or recurrent TIA or&#xD;
           stroke.&#xD;
&#xD;
        6. To assess and audit the overall quality of care received by patients admitted for first&#xD;
           or recurrent TIA or stroke.&#xD;
&#xD;
        7. To perform other future analyses, sanctioned by the Philippine Neurological Association&#xD;
           (PNA), that may improve knowledge on the care of patients with first and/or recurrent&#xD;
           TIA or stroke.&#xD;
&#xD;
      All eligible patients will be assigned a study identification (ID) number and included in the&#xD;
      site log kept confidentially in each site. Corresponding anonymized data on demographics,&#xD;
      medical history, stroke sub-type, in-hospital management and discharge outcomes will be&#xD;
      collected from each patient and entered in the database using a secure online data collection&#xD;
      tool.&#xD;
&#xD;
      Collective data will be extracted, summarized, and analyzed for the secondary objectives&#xD;
      every year with oversight provided by the Philippine Neurological Association.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>10 Days</target_duration>
  <primary_outcome>
    <measure>In-hospital caseload</measure>
    <time_frame>3 years</time_frame>
    <description>Number of TIA and stroke cases admitted in participating sites.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>In-hospital diagnostic procedure (brain scan)</measure>
    <time_frame>From admission to discharge, may be up to 1 month</time_frame>
    <description>Rate of performance of brain scan.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital diagnostic procedures (electrocardiogram)</measure>
    <time_frame>From admission to discharge, may be up to 1 month</time_frame>
    <description>Rate of performance of electrocardiogram.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital diagnostic procedures (echocardiogram)</measure>
    <time_frame>From admission to discharge, may be up to 1 month</time_frame>
    <description>Rate of performance of echocardiogram.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital diagnostic procedures (cerebral vascular studies)</measure>
    <time_frame>From admission to discharge, may be up to 1 month</time_frame>
    <description>Rate of performance of any cerebral vascular study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital therapeutic management (thrombolysis)</measure>
    <time_frame>From admission to discharge, may be up to 1 month</time_frame>
    <description>Rate of treatment with thrombolysis (intravenous and/or endovascular).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital therapeutic management (anti-thrombotics)</measure>
    <time_frame>From admission to discharge, may be up to 1 month</time_frame>
    <description>Rate of treatment with any anti-thrombotic (anti-platelet and/or anti-coagulant).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital therapeutic management (rehabilitation)</measure>
    <time_frame>From admission to discharge, may be up to 1 month</time_frame>
    <description>Rate of rehabilitation (physical therapy and/or occupational therapy and or speech therapy).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital complications from TIA or stroke</measure>
    <time_frame>From admission to discharge, may be up to 1 month</time_frame>
    <description>Rate of complications arising from TIA or stroke.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital status at hospital discharge</measure>
    <time_frame>At discharge, may be up to 1 month</time_frame>
    <description>Alive or dead</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status at hospital discharge</measure>
    <time_frame>At discharge, may be up to 1 month</time_frame>
    <description>modified Rankin Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological status at hospital discharge</measure>
    <time_frame>At discharge, may be up to 1 month</time_frame>
    <description>National Institute of Health Stroke Scale</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30000</enrollment>
  <condition>Transient Ischemic Attack</condition>
  <condition>Ischemic Stroke</condition>
  <condition>Intracerebral Hemorrhage</condition>
  <condition>Subarachnoid Hemorrhage</condition>
  <condition>Cerebral Venous Thrombosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients admitted at the participating sites fulfilling all inclusion and none of the&#xD;
        exclusion criteria are eligible to be included.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Diagnosis of first or recurrent TIA, ischemic or hemorrhagic stroke, or cerebral&#xD;
             venous thrombosis (CVT)&#xD;
&#xD;
          2. 18 years old or older&#xD;
&#xD;
          3. Admitted in the participating hospital&#xD;
&#xD;
          4. If required by the institutional review board/ethics committee, signed or verbal&#xD;
             informed consent for participation in the study from the patient or a legal&#xD;
             representative&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with previous TIA or stroke who are admitted to the hospital for medical&#xD;
             conditions other than an acute stroke, e.g., patient with non-acute stroke admitted&#xD;
             for pneumonia, rehabilitation, or procedures, such as gastric tube insertion, etc.&#xD;
&#xD;
          2. Any condition which, in the study investigator's opinion, may jeopardize the patient&#xD;
             by his/her participation in this study or affect the validity of the study results&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert N Gan, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Philippine Neurological Association</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Oliber Biaro</last_name>
    <phone>+63 8723 2102</phone>
    <phone_ext>5006</phone_ext>
    <email>philneuro.research@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert N Gan, MD</last_name>
    <phone>+63 8723 0101</phone>
    <phone_ext>5008</phone_ext>
    <email>philneuro.research@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Baguio General Hospital and Medical Center</name>
      <address>
        <city>Baguio City</city>
        <state>Benguet</state>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Harold B Hiyadan, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chong Hua Hospital</name>
      <address>
        <city>Cebu City</city>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Teresa A Cañete, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Makati Medical Center</name>
      <address>
        <city>Makati City</city>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raquel M Alvarez, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jose R. Reyes Memorial Medical Center</name>
      <address>
        <city>Manila</city>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cyrus G Escabillas, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Santo Tomas Hospital</name>
      <address>
        <city>Manila</city>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johnny K Lokin, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of the Philippines - Philippine General Hospital</name>
      <address>
        <city>Manila</city>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Epifania V Collantes, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Medical City</name>
      <address>
        <city>Pasig City</city>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gemmalynn B Sarapuddin, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>East Avenue Medical Center</name>
      <address>
        <city>Quezon City</city>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan Neftalie A Juangco, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Quirino Memorial Medical Center</name>
      <address>
        <city>Quezon City</city>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Oliver C Co, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Luke's Medical Center (QC, BGC)</name>
      <address>
        <city>Quezon City</city>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Cristina Z Macrohon-Valdez, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of the East - Ramon Magsaysay Memorial Medical Center</name>
      <address>
        <city>Quezon City</city>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monique Therese S Punsalan, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Philippines</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 13, 2021</study_first_submitted>
  <study_first_submitted_qc>July 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 22, 2021</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Cerebral Hemorrhage</mesh_term>
    <mesh_term>Ischemic Attack, Transient</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

